Annual Retained Earnings:
$1.13B+$248.69M(+28.30%)Summary
- As of today, JAZZ annual retained earnings is $1.13 billion, with the most recent change of +$248.69 million (+28.30%) on December 31, 2024.
 - During the last 3 years, JAZZ annual retained earnings has risen by +$297.12 million (+35.79%).
 - JAZZ annual retained earnings is now -2.81% below its all-time high of $1.16 billion, reached on December 31, 2020.
 
Performance
JAZZ Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Retained Earnings:
$191.31M-$843.49M(-81.51%)Summary
- As of today, JAZZ quarterly retained earnings is $191.31 million, with the most recent change of -$843.49 million (-81.51%) on June 30, 2025.
 - Over the past year, JAZZ quarterly retained earnings has dropped by -$679.87 million (-78.04%).
 - JAZZ quarterly retained earnings is now -85.07% below its all-time high of $1.28 billion, reached on March 31, 2021.
 
Performance
JAZZ Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
JAZZ Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | 
|---|---|---|
| 1Y1 Year | +28.3% | -78.0% | 
| 3Y3 Years | +35.8% | -80.8% | 
| 5Y5 Years | +5.6% | -78.2% | 
JAZZ Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +53.7% | -83.0% | at low | 
| 5Y | 5-Year | -2.8% | +53.7% | -85.1% | at low | 
| All-Time | All-Time | -2.8% | +322.1% | -85.1% | +137.2% | 
JAZZ Retained Earnings History
| Date | Annual | Quarterly | 
|---|---|---|
| Jun 2025 | -  | $191.31M(-81.5%)  | 
| Mar 2025 | -  | $1.03B(-8.2%)  | 
| Dec 2024 | $1.13B(+28.3%)  | $1.13B(+20.4%)  | 
| Sep 2024 | -  | $936.23M(+7.5%)  | 
| Jun 2024 | -  | $871.18M(+0.8%)  | 
| Mar 2024 | -  | $864.04M(-1.7%)  | 
| Dec 2023 | $878.66M(+19.8%)  | $878.66M(-0.6%)  | 
| Sep 2023 | -  | $884.30M(+8.9%)  | 
| Jun 2023 | -  | $811.85M(+1.1%)  | 
| Mar 2023 | -  | $803.01M(+9.5%)  | 
| Dec 2022 | $733.59M(-11.6%)  | $733.59M(-24.7%)  | 
| Sep 2022 | -  | $974.31M(-2.0%)  | 
| Jun 2022 | -  | $993.96M(+3.6%)  | 
| Mar 2022 | -  | $959.35M(+15.6%)  | 
| Dec 2021 | $830.23M(-28.4%)  | $830.23M(-4.1%)  | 
| Sep 2021 | -  | $865.58M(-5.8%)  | 
| Jun 2021 | -  | $918.41M(-28.3%)  | 
| Mar 2021 | -  | $1.28B(+10.5%)  | 
| Dec 2020 | $1.16B(+8.6%)  | $1.16B(+13.0%)  | 
| Sep 2020 | -  | $1.03B(+16.9%)  | 
| Jun 2020 | -  | $878.25M(+13.9%)  | 
| Mar 2020 | -  | $770.93M(-27.8%)  | 
| Dec 2019 | $1.07B(+27.0%)  | $1.07B(-3.3%)  | 
| Sep 2019 | -  | $1.10B(+8.1%)  | 
| Jun 2019 | -  | $1.02B(+24.6%)  | 
| Mar 2019 | -  | $819.85M(-2.5%)  | 
| Dec 2018 | $841.05M(-8.4%)  | $841.05M(-25.5%)  | 
| Sep 2018 | -  | $1.13B(+12.8%)  | 
| Jun 2018 | -  | $1.00B(+7.7%)  | 
| Mar 2018 | -  | $929.05M(+1.2%)  | 
| Dec 2017 | $917.96M(+73.6%)  | $917.96M(+26.1%)  | 
| Sep 2017 | -  | $728.12M(+5.5%)  | 
| Jun 2017 | -  | $690.16M(+14.7%)  | 
| Mar 2017 | -  | $601.52M(+13.7%)  | 
| Dec 2016 | $528.91M(+74.7%)  | $528.91M(+67.7%)  | 
| Sep 2016 | -  | $315.42M(-2.9%)  | 
| Jun 2016 | -  | $324.84M(+34.0%)  | 
| Mar 2016 | -  | $242.44M(-19.9%)  | 
| Date | Annual | Quarterly | 
|---|---|---|
| Dec 2015 | $302.69M(+772.2%)  | $302.69M(+16.3%)  | 
| Sep 2015 | -  | $260.18M(+43.1%)  | 
| Jun 2015 | -  | $181.83M(+91.3%)  | 
| Mar 2015 | -  | $95.07M(+173.9%)  | 
| Dec 2014 | $34.70M(+87.3%)  | $34.70M(+200.1%)  | 
| Sep 2014 | -  | -$34.67M(+35.7%)  | 
| Jun 2014 | -  | -$53.95M(+27.2%)  | 
| Mar 2014 | -  | -$74.12M(-499.9%)  | 
| Dec 2013 | $18.53M(+130.2%)  | $18.53M(+793.0%)  | 
| Sep 2013 | -  | -$2.67M(+90.9%)  | 
| Jun 2013 | -  | -$29.26M(-63.8%)  | 
| Mar 2013 | -  | -$17.87M(+70.8%)  | 
| Dec 2012 | -$61.30M(+82.5%)  | -$61.30M(+76.6%)  | 
| Sep 2012 | -  | -$261.85M(+11.3%)  | 
| Jun 2012 | -  | -$295.06M(+8.4%)  | 
| Mar 2012 | -  | -$322.20M(+7.9%)  | 
| Dec 2011 | -$349.88M(+26.3%)  | -$349.88M(+9.7%)  | 
| Sep 2011 | -  | -$387.36M(+7.7%)  | 
| Jun 2011 | -  | -$419.84M(+7.3%)  | 
| Mar 2011 | -  | -$453.04M(+4.6%)  | 
| Dec 2010 | -$474.87M(+6.5%)  | -$474.87M(+4.9%)  | 
| Sep 2010 | -  | -$499.32M(+2.6%)  | 
| Jun 2010 | -  | -$512.57M(-1.3%)  | 
| Mar 2010 | -  | -$506.18M(+0.3%)  | 
| Dec 2009 | -$507.64M(-1.4%)  | -$507.64M(+1.1%)  | 
| Sep 2009 | -  | -$513.30M(-0.3%)  | 
| Jun 2009 | -  | -$511.63M(+0.4%)  | 
| Mar 2009 | -  | -$513.80M(-2.6%)  | 
| Dec 2008 | -$500.81M(-58.2%)  | -$500.81M(-12.8%)  | 
| Sep 2008 | -  | -$443.87M(-6.9%)  | 
| Jun 2008 | -  | -$415.06M(-14.3%)  | 
| Mar 2008 | -  | -$363.18M(-14.8%)  | 
| Dec 2007 | -$316.47M(-78.1%)  | -$316.47M(-23.4%)  | 
| Sep 2007 | -  | -$256.45M(-8.2%)  | 
| Jun 2007 | -  | -$237.09M(-20.2%)  | 
| Mar 2007 | -  | -$197.23M(-11.0%)  | 
| Dec 2006 | -$177.64M(-48.8%)  | -$177.64M(-50.2%)  | 
| Dec 2005 | -$119.39M  | -$118.25M  | 
FAQ
- What is Jazz Pharmaceuticals plc annual retained earnings?
 - What is the all-time high annual retained earnings for Jazz Pharmaceuticals plc?
 - What is Jazz Pharmaceuticals plc annual retained earnings year-on-year change?
 - What is Jazz Pharmaceuticals plc quarterly retained earnings?
 - What is the all-time high quarterly retained earnings for Jazz Pharmaceuticals plc?
 - What is Jazz Pharmaceuticals plc quarterly retained earnings year-on-year change?
 
What is Jazz Pharmaceuticals plc annual retained earnings?
The current annual retained earnings of JAZZ is $1.13B
What is the all-time high annual retained earnings for Jazz Pharmaceuticals plc?
Jazz Pharmaceuticals plc all-time high annual retained earnings is $1.16B
What is Jazz Pharmaceuticals plc annual retained earnings year-on-year change?
Over the past year, JAZZ annual retained earnings has changed by +$248.69M (+28.30%)
What is Jazz Pharmaceuticals plc quarterly retained earnings?
The current quarterly retained earnings of JAZZ is $191.31M
What is the all-time high quarterly retained earnings for Jazz Pharmaceuticals plc?
Jazz Pharmaceuticals plc all-time high quarterly retained earnings is $1.28B
What is Jazz Pharmaceuticals plc quarterly retained earnings year-on-year change?
Over the past year, JAZZ quarterly retained earnings has changed by -$679.87M (-78.04%)